Efficacy and safety of modified fluorouracil/leucovorin plus irinotecan and oxaliplatin (mFOLFIRINOX) compared with S‐1 as second‐line chemotherapy in metastatic pancreatic cancer-Reference-Cited by-同舟云学术

Efficacy and safety of modified fluorouracil/leucovorin plus irinotecan and oxaliplatin (mFOLFIRINOX) compared with S‐1 as second‐line chemotherapy in metastatic pancreatic cancer

Published:2021-05-10 Issue:6 Volume:5 Page:679-685
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Ikezawa Kenji¹^ORCID,Kiyota Ryosuke¹,Takada Ryoji¹,Daiku Kazuma¹,Maeda Shingo¹,Imai Toshihiro¹,Abe Yutaro¹,Kai Yugo¹,Yamai Takuo¹,Fukutake Nobuyasu¹,Nakabori Tasuku¹,Ashida Reiko²,Uehara Hiroyuki¹,Tabuchi Takahiro³,Katayama Kazuhiro¹,Ohkawa Kazuyoshi¹

Affiliation:

1. Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan

2. Department of Cancer Survey and Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan

3. Cancer Control Center Osaka International Cancer Institute Osaka Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12555

Reference31 articles.

1. Cancer statistics, 2020